Treatment of hepatobiliary disease with 15-keto-prostaglandin co

Details Treatment of hepatobiliary disease with 15-keto-prostaglandin co Treatment of hepatobiliary disease with 15-keto-prostaglandin co

1990-10-19

1992-03-17

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514573, A61K 3119, A61K 31215, A61K 31557

Patent

active

050969277

ABSTRACT:
A method for treatment of a hepatobiliary disease which comprises administering, to a subject in need of such treatment, a 15-ketoprostaglandin compound in an amount effective in treatment of the hepatobiliary disease.

REFERENCES:
patent: 4374856 (1983-02-01), Ruwart
patent: 4464388 (1984-08-01), Sakai
patent: 4503058 (1985-03-01), Sakai
JPA-129218/1987 and Chem. Abst., 107, 223291z.
Aeta Physiologica Scandinavica, 66, pp. 509-510 (1966).

Affiliated with

Also associated with

Rating

Treatment of hepatobiliary disease with 15-keto-prostaglandin co does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of hepatobiliary disease with 15-keto-prostaglandin co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of hepatobiliary disease with 15-keto-prostaglandin co will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1476204